Bio Ebitda from 2010 to 2024
BIO Stock | USD 293.85 1.88 0.64% |
EBITDA | First Reported 1985-09-30 | Previous Quarter 150.8 M | Current Value 99.8 M | Quarterly Volatility 51.6 M |
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many exotic indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
Bio | Ebitda |
Latest Bio Rad's Ebitda Growth Pattern
Below is the plot of the Ebitda of Bio Rad Laboratories over the last few years. It is Bio Rad's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
Ebitda | 10 Years Trend |
|
Ebitda |
Timeline |
Bio Ebitda Regression Statistics
Arithmetic Mean | 412,180,720 | |
Geometric Mean | 328,317,474 | |
Coefficient Of Variation | 42.82 | |
Mean Deviation | 135,522,901 | |
Median | 389,993,000 | |
Standard Deviation | 176,506,331 | |
Sample Variance | 31154.5T | |
Range | 654.2M | |
R-Value | 0.79 | |
Mean Square Error | 12838.6T | |
R-Squared | 0.62 | |
Significance | 0.0005 | |
Slope | 31,010,459 | |
Total Sum of Squares | 436162.8T |
Bio Ebitda History
About Bio Rad Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bio Rad income statement, its balance sheet, and the statement of cash flows. Bio Rad investors use historical funamental indicators, such as Bio Rad's Ebitda, to determine how well the company is positioned to perform in the future. Although Bio Rad investors may use each financial statement separately, they are all related. The changes in Bio Rad's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Rad's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bio Rad Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bio Rad. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
EBITDA | 576.2 M | 605 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Bio Rad Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.797 | Earnings Share (10.68) | Revenue Per Share 90.024 | Quarterly Revenue Growth (0.1) | Return On Assets 0.0169 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.